Amgen
AMGN
2,132 hedge funds and large institutions have $90.2B invested in Amgen in 2021 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 873 increasing their positions, 847 reducing their positions, and 146 closing their positions.
3% more repeat investments, than reductions
Existing positions increased: 873 | Existing positions reduced: 847
0.71% less ownership
Funds ownership: 75.47% → 74.76% (-0.71%)
9% less call options, than puts
Call options by funds: $948M | Put options by funds: $1.04B
3% less funds holding
Funds holding: 2,195 → 2,132 (-63)
14% less capital invested
Capital invested by funds: $105B → $90.2B (-$15.1B)
22% less first-time investments, than exits
New positions opened: 114 | Existing positions closed: 146
40% less funds holding in top 10
Funds holding in top 10: 43 → 26 (-17)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$274M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$212M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
+$175M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$169M |
| 5 |
Barclays
London,
United Kingdom
|
+$135M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
-$788M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$595M |
| 3 |
JP Morgan Chase
New York
|
-$404M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$260M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$174M |
AMGN Hedge Fund Activity: Q3 2021 in Review
2,132 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2021, worth a combined $90.2B — down 14% from $105B a quarter earlier.
Sellers outnumbered buyers: 146 funds closed out of AMGN and 114 opened new positions — a net loss of 32 holders — while 847 trimmed existing stakes and 873 added.
The largest buyer was BlackRock, adding an estimated $274M. The largest seller was ClearBridge Investments, cutting an estimated $788M.
- 2,132 institutional investors held Amgen (AMGN) as of Q3 2021, down from 2,195 in Q2 2021.
- Funds reported $90.2B of Amgen stock for Q3 2021, down 14% quarter-over-quarter.
- 114 funds opened new Amgen positions in Q3 2021 and 146 closed out, a net change of -32 holders.
- The largest Amgen buyer in Q3 2021 was BlackRock, an estimated $274M added.
- The largest Amgen seller in Q3 2021 was ClearBridge Investments, an estimated $788M sold.
Based on aggregated 13F filings for Q3 2021.